Insider · CIK 0001666236
Steve E. Krognes
director
Files at GH (Guardant Health, Inc.), DNLI (Denali Therapeutics Inc.), PLRX (PLIANT THERAPEUTICS, INC.). First filing Jan 3, 2025, latest Sep 17, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $1.8M sold
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
DNLI: Denali Therapeutics Inc.
DNLIOct 9, 2026 · close 19.45
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
GH: Guardant Health, Inc.
GHOct 9, 2026 · close 167.47
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 65Notable | Guardant Health, Inc. | $1.2M 6,674 shares | -46% | - | |
| 43Moderate | Denali Therapeutics Inc. | $69k 3,339 shares | -11% | - | |
| 50Moderate | Denali Therapeutics Inc. | $608k 30,000 shares | -51% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | GH Guardant Health, Inc. | SOpen-market sale Common Stock | -1,103 | $174.46 | $192k | 13,477 | 25 d ago |
| Sep 16, 2026 | GH Guardant Health, Inc. | SOpen-market sale Common Stock | -3,300 | $175.42 | $579k | 10,177 | 25 d ago |
| Sep 16, 2026 | GH Guardant Health, Inc. | SOpen-market sale Common Stock | -1,300 | $176.34 | $229k | 8,877 | 25 d ago |
| Sep 16, 2026 | GH Guardant Health, Inc. | SOpen-market sale Common Stock | -971 | $177.48 | $172k | 7,906 | 25 d ago |
| Aug 31, 2025 | GH Guardant Health, Inc. | MOption exercise Common Stock | +155 | $0.00 | $0 | 18,128 | Sep 3, 2025 |
| Aug 31, 2025 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -155 | $0.00 | $0 | 1,543 | Sep 3, 2025 |
| Jul 31, 2025 | GH Guardant Health, Inc. | MOption exercise Common Stock | +154 | $0.00 | $0 | 17,973 | Aug 4, 2025 |
| Jul 31, 2025 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -154 | $0.00 | $0 | 1,698 | Aug 4, 2025 |
| Jun 30, 2025 | GH Guardant Health, Inc. | MOption exercise Common Stock | +154 | $0.00 | $0 | 17,819 | Jul 2, 2025 |
| Jun 30, 2025 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -154 | $0.00 | $0 | 1,852 | Jul 2, 2025 |
| Jun 18, 2025 | GH Guardant Health, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +6,833 | $0.00 | $0 | 6,833 | Jun 20, 2025 |
| Jun 18, 2025 | GH Guardant Health, Inc. | AGrant or award Restricted Stock Unitsderivative | +4,203 | $0.00 | $0 | 4,203 | Jun 20, 2025 |
| Jun 12, 2025 | GH Guardant Health, Inc. | MOption exercise Common Stock | +6,674 | $0.00 | $0 | 17,665 | Jun 16, 2025 |
| Jun 12, 2025 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -6,674 | $0.00 | $0 | 0 | Jun 16, 2025 |
| Jun 5, 2025 | PLRX PLIANT THERAPEUTICS, INC. | AGrant or award Common Stock (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 9, 2025 |
| Jun 3, 2025 | DNLI Denali Therapeutics Inc. | AGrant or award Common Stock | +6,037 | $0.00 | $0 | 31,794 | Jun 5, 2025 |
| Jun 3, 2025 | DNLI Denali Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +18,111 | $0.00 | $0 | 18,111 | Jun 5, 2025 |
| May 31, 2025 | GH Guardant Health, Inc. | MOption exercise Common Stock | +154 | $0.00 | $0 | 10,991 | Jun 2, 2025 |
| May 31, 2025 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -154 | $0.00 | $0 | 2,006 | Jun 2, 2025 |
| Apr 30, 2025 | GH Guardant Health, Inc. | MOption exercise Common Stock | +155 | $0.00 | $0 | 10,837 | May 1, 2025 |
| Apr 30, 2025 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -155 | $0.00 | $0 | 2,160 | May 1, 2025 |
| Mar 31, 2025 | GH Guardant Health, Inc. | MOption exercise Common Stock | +154 | $0.00 | $0 | 10,682 | Apr 2, 2025 |
| Mar 31, 2025 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -154 | $0.00 | $0 | 2,315 | Apr 2, 2025 |
| Feb 28, 2025 | GH Guardant Health, Inc. | MOption exercise Common Stock | +154 | $0.00 | $0 | 10,528 | Mar 4, 2025 |
| Feb 28, 2025 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -154 | $0.00 | $0 | 2,469 | Mar 4, 2025 |
| Jan 31, 2025 | GH Guardant Health, Inc. | MOption exercise Common Stock | +154 | $0.00 | $0 | 10,374 | Feb 4, 2025 |
| Jan 31, 2025 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -154 | $0.00 | $0 | 2,623 | Feb 4, 2025 |
| Jan 7, 2025 | DNLI Denali Therapeutics Inc. | SOpen-market sale Common Stock | -3,339 | $20.81 | $69k | 25,757 | Jan 8, 2025 |
| Dec 31, 2024 | DNLI Denali Therapeutics Inc. | SOpen-market sale Common Stock10b5-1 | -30,000 | $20.25 | $608k | 29,096 | Jan 3, 2025 |
| Dec 31, 2024 | GH Guardant Health, Inc. | MOption exercise Common Stock | +155 | $0.00 | $0 | 10,220 | Jan 2, 2025 |
| Dec 31, 2024 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -155 | $0.00 | $0 | 2,777 | Jan 2, 2025 |
| Nov 30, 2024 | GH Guardant Health, Inc. | MOption exercise Common Stock | +154 | $0.00 | $0 | 10,065 | Dec 2, 2024 |
| Nov 30, 2024 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -154 | $0.00 | $0 | 2,932 | Dec 2, 2024 |
| Oct 31, 2024 | GH Guardant Health, Inc. | MOption exercise Common Stock | +154 | $0.00 | $0 | 9,911 | Nov 4, 2024 |
| Oct 31, 2024 | GH Guardant Health, Inc. | MOption exercise Restricted Stock Unitsderivative | -154 | $0.00 | $0 | 3,086 | Nov 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.